{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:37:00Z","timestamp":1794361020843,"version":"4.9.0"},"reference-count":216,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T00:00:00Z","timestamp":1669248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81630037"],"award-info":[{"award-number":["81630037"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>Pulmonary arterial hypertension (PAH) is a rare but progressive and lethal vascular disease of diverse etiologies, mainly caused by proliferation of endothelial cells, smooth muscle cells in the pulmonary artery, and fibroblasts, which ultimately leads to right-heart hypertrophy and cardiac failure. Recent genetic studies of childhood-onset PAH report that there is a greater genetic burden in children than in adults. Since the first-identified pathogenic gene of PAH, <jats:italic>BMPR2<\/jats:italic>, which encodes bone morphogenetic protein receptor 2, a receptor in the transforming growth factor-\u03b2 superfamily, was discovered, novel causal genes have been identified and substantially sharpened our insights into the molecular genetics of childhood-onset PAH. Currently, some newly identified deleterious genetic variants in additional genes implicated in childhood-onset PAH, such as potassium channels (<jats:italic>KCNK3<\/jats:italic>) and transcription factors (<jats:italic>TBX4<\/jats:italic> and <jats:italic>SOX17<\/jats:italic>), have been reported and have greatly updated our understanding of the disease mechanism. In this review, we summarized and discussed the advances of genetic variants underlying childhood-onset PAH susceptibility and potential mechanism, and the most promising <jats:italic>BMPR2<\/jats:italic> gene therapy and gene delivery approaches to treat childhood-onset PAH in the future.<\/jats:p>","DOI":"10.3389\/fgene.2022.961848","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T11:29:27Z","timestamp":1669289367000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Genes in pediatric pulmonary arterial hypertension and the most promising BMPR2 gene therapy"],"prefix":"10.3389","volume":"13","author":[{"given":"Lingling","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhong","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2003337","DOI":"10.1183\/13993003.03337-2020","article-title":"Characterisation of paediatric pulmonary hypertensive vascular disease from the PPHNet Registry","volume":"59","author":"Abman","year":"2022","journal-title":"Eur. Respir. J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1208\/s12248-009-9143-y","article-title":"Nonviral gene delivery: Principle, limitations, and recent progress","volume":"11","author":"Al-Dosari","year":"2009","journal-title":"AAPS J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1165\/rcmb.2016-0301PS","article-title":"Gene editing and genetic lung disease. Basic research meets therapeutic application","volume":"56","author":"Alapati","year":"2017","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"eaav8375","DOI":"10.1126\/scitranslmed.aav8375","article-title":"In utero gene editing for monogenic lung disease","volume":"11","author":"Alapati","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0960-9822(00)80016-0","article-title":"A molecular pathway leading to endoderm formation in zebrafish","volume":"9","author":"Alexander","year":"1999","journal-title":"Curr. Biol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: From concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/S2213-2600(15)00245-3","article-title":"Repeated nebulisation of non-viral cftr gene therapy in patients with cystic fibrosis: A randomised, double-blind, placebo-controlled, phase 2b trial","volume":"3","author":"Alton","year":"2015","journal-title":"Lancet. Respir. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1136\/thoraxjnl-2016-208406","article-title":"Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis","volume":"72","author":"Alton","year":"2017","journal-title":"Thorax"},{"key":"B9","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1517\/17425240902927841","article-title":"Targeted gene delivery to the lung","volume":"6","author":"Aneja","year":"2009","journal-title":"Expert Opin. Drug Deliv."},{"key":"B10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1479-0556-2-9","article-title":"The use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene delivery","volume":"2","author":"Anson","year":"2004","journal-title":"Genet. Vaccines Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1161\/CIRCULATIONAHA.108.847707","article-title":"Basic science of pulmonary arterial hypertension for clinicians: New concepts and experimental therapies","volume":"121","author":"Archer","year":"2010","journal-title":"Circulation"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e1002866","DOI":"10.1371\/journal.pgen.1002866","article-title":"Multiple roles and interactions of tbx4 and tbx5 in development of the respiratory system","volume":"8","author":"Arora","year":"2012","journal-title":"PLoS Genet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1172\/JCI15780","article-title":"Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins","volume":"110","author":"Auricchio","year":"2002","journal-title":"J. Clin. Invest."},{"key":"B14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1164\/rccm.201605-0905PP","article-title":"Translational advances in the field of pulmonary hypertension molecular medicine of pulmonary arterial hypertension. From population genetics to precision medicine and gene editing","volume":"195","author":"Austin","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.ajhg.2010.01.038","article-title":"Identification of a recurrent microdeletion at 17q23.1q23.2 flanked by segmental duplications associated with heart defects and limb abnormalities","volume":"86","author":"Ballif","year":"2010","journal-title":"Am. J. Hum. Genet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1183\/09031936.00056110","article-title":"Pulmonary arterial hypertension: A comparison between children and adults","volume":"37","author":"Barst","year":"2011","journal-title":"Eur. Respir. J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1161\/01.cir.99.9.1197","article-title":"Vasodilator therapy for primary pulmonary hypertension in children","volume":"99","author":"Barst","year":"1999","journal-title":"Circulation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1161\/CIRCULATIONAHA.111.026591","article-title":"Survival in childhood pulmonary arterial hypertension: Insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management","volume":"125","author":"Barst","year":"2012","journal-title":"Circulation"},{"key":"B19","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0140-6736(11)61621-8","article-title":"Clinical features of paediatric pulmonary hypertension: A registry study","volume":"379","author":"Berger","year":"2012","journal-title":"Lancet"},{"key":"B20","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.bbadis.2009.07.003","article-title":"The emerging role of tgf-beta superfamily coreceptors in cancer","volume":"1792","author":"Bernabeu","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"B21","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.ymthe.2019.11.027","article-title":"Aav1.Serca2a gene therapy reverses pulmonary fibrosis by blocking the stat3\/foxm1 pathway and promoting the snon\/ski axis","volume":"28","author":"Bisserier","year":"2020","journal-title":"Mol. Ther."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1086\/421331","article-title":"Mutations in the human tbx4 gene cause small patella syndrome","volume":"74","author":"Bongers","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/gt.2008.14","article-title":"Progress and prospects: Gene therapy for genetic diseases with helper-dependent adenoviral vectors","volume":"15","author":"Brunetti-Pierri","year":"2008","journal-title":"Gene Ther."},{"key":"B24","first-page":"446","article-title":"Progress towards the clinical application of helper-dependent adenoviral vectors for liver and lung gene therapy","volume":"8","author":"Brunetti-Pierri","year":"2006","journal-title":"Curr. Opin. Mol. Ther."},{"key":"B25","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1089\/vim.2004.17.327","article-title":"Adenoviral vectors for gene replacement therapy","volume":"17","author":"Cao","year":"2004","journal-title":"Viral Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1089\/hum.2017.201","article-title":"Transducing airway basal cells with a helper-dependent adenoviral vector for lung gene therapy","volume":"29","author":"Cao","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/hgtb.2015.140","article-title":"Expressing transgenes that exceed the packaging capacity of adeno-associated virus capsids","volume":"27","author":"Chamberlain","year":"2016","journal-title":"Hum. Gene Ther. Methods"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1517\/14712598.2011.583914","article-title":"Human jc virus-like particles as a gene delivery vector","volume":"11","author":"Chang","year":"2011","journal-title":"Expert Opin. Biol. Ther."},{"key":"B29","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F","article-title":"Expression of the t-box family genes, tbx1-tbx5, during early mouse development","volume":"206","author":"Chapman","year":"1996","journal-title":"Dev. Dyn."},{"key":"B30","doi-asserted-by":"publisher","first-page":"L202","DOI":"10.1152\/ajplung.00064.2004","article-title":"Antiproliferative effects of calcitonin gene-related peptide in aortic and pulmonary artery smooth muscle cells","volume":"288","author":"Chattergoon","year":"2005","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.amjcard.2012.04.035","article-title":"Outcomes of childhood pulmonary arterial hypertension in bmpr2 and alk1 mutation carriers","volume":"110","author":"Chida","year":"2012","journal-title":"Am. J. Cardiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"6138","DOI":"10.1128\/JVI.72.7.6138-6145.1998","article-title":"Role of e4 in eliciting cd4 t-cell and b-cell responses to adenovirus vectors delivered to murine and nonhuman primate lungs","volume":"72","author":"Chirmule","year":"1998","journal-title":"J. Virol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1165\/rcmb.2019-0006OC","article-title":"A novel aav-mediated gene delivery system corrects cftr function in pigs","volume":"61","author":"Cooney","year":"2019","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1091\/mbc.E17-06-0421","article-title":"A disease-associated frameshift mutation in caveolin-1 disrupts caveolae formation and function through introduction of a de novo er retention signal","volume":"28","author":"Copeland","year":"2017","journal-title":"Mol. Biol. Cell"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1038\/ncomms3609","article-title":"Sox17 is indispensable for acquisition and maintenance of arterial identity","volume":"4","author":"Corada","year":"2013","journal-title":"Nat. Commun."},{"key":"B36","doi-asserted-by":"publisher","first-page":"10433","DOI":"10.3390\/ijms231810433","article-title":"Clinical implications of the genetic background in pediatric pulmonary arterial hypertension: Data from the Spanish rehiped registry","volume":"23","author":"Cruz-Utrilla","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nature.2016.20988","article-title":"Crispr gene-editing tested in a person for the first time","volume":"539","author":"Cyranoski","year":"2016","journal-title":"Nature"},{"key":"B38","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1161\/CIRCRESAHA.107.165530","article-title":"Bone morphogenetic protein-9 is a circulating vascular quiescence factor","volume":"102","author":"David","year":"2008","journal-title":"Circ. Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1182\/blood-2006-07-034124","article-title":"Identification of bmp9 and bmp10 as functional activators of the orphan activin receptor-like kinase 1 (alk1) in endothelial cells","volume":"109","author":"David","year":"2007","journal-title":"Blood"},{"key":"B40","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1128\/CMR.00008-08","article-title":"Gene therapy using adeno-associated virus vectors","volume":"21","author":"Daya","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"B41","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/gt.2009.166","article-title":"The sp-c promoter facilitates alveolar type ii epithelial cell-specific plasmid nuclear import and gene expression","volume":"17","author":"Degiulio","year":"2010","journal-title":"Gene Ther."},{"key":"B42","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1086\/303059","article-title":"Familial primary pulmonary hypertension (gene pph1) is caused by mutations in the bone morphogenetic protein receptor-ii gene","volume":"67","author":"Deng","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"B43","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1164\/rccm.201411-1985LE","article-title":"Endothelial chromosome 13 deletion in congenital heart disease-associated pulmonary arterial hypertension dysregulates smad9 signaling","volume":"191","author":"Drake","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1164\/rccm.201106-1130OC","article-title":"Altered microrna processing in heritable pulmonary arterial hypertension: An important role for smad-8","volume":"184","author":"Drake","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1146\/annurev.physiol.65.092101.142426","article-title":"Current status of gene therapy for inherited lung diseases","volume":"65","author":"Driskell","year":"2003","journal-title":"Annu. Rev. Physiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1056\/NEJMoa021650","article-title":"Signaling molecules in nonfamilial pulmonary hypertension","volume":"348","author":"Du","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"971","DOI":"10.3389\/fphar.2018.00971","article-title":"Non-viral delivery of nucleic acids: Insight into mechanisms of overcoming intracellular barriers","volume":"9","author":"Durymanov","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1161\/CIRCULATIONAHA.105.601930","article-title":"Relationship of bmpr2 mutations to vasoreactivity in pulmonary arterial hypertension","volume":"113","author":"Elliott","year":"2006","journal-title":"Circulation"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1089\/hum.1994.5.10-1217","article-title":"Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in e2a","volume":"5","author":"Engelhardt","year":"1994","journal-title":"Hum. Gene Ther."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1801371","DOI":"10.1183\/13993003.01371-2018","article-title":"Widening the landscape of heritable pulmonary hypertension mutations in paediatric and adult cases","volume":"53","author":"Eyries","year":"2019","journal-title":"Eur. Respir. J."},{"key":"B51","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.omtm.2019.01.003","article-title":"Novel chimeric gene therapy vectors based on adeno-associated virus and four different mammalian bocaviruses","volume":"12","author":"Fakhiri","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.4161\/hv.29594","article-title":"Pre-existing immunity against ad vectors: Humoral, cellular, and innate response, what's important?","volume":"10","author":"Fausther-Bovendo","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"B53","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/resp.12712","article-title":"Bmpr2 gene delivery reduces mutation-related pah and counteracts tgf-beta-mediated pulmonary cell signalling","volume":"21","author":"Feng","year":"2016","journal-title":"Respirology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1038\/s41467-019-09693-x","article-title":"Multifunctional crispr-cas9 with engineered immunosilenced human t cell epitopes","volume":"10","author":"Ferdosi","year":"2019","journal-title":"Nat. Commun."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/sj.gt.3302991","article-title":"Sendai virus-mediated cftr gene transfer to the airway epithelium","volume":"14","author":"Ferrari","year":"2007","journal-title":"Gene Ther."},{"key":"B56","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1089\/hum.2005.16.643","article-title":"Adeno-associated virus-mediated gene transfer for lung diseases","volume":"16","author":"Flotte","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"B57","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.biocel.2009.08.017","article-title":"Soxf genes: Key players in the development of the cardio-vascular system","volume":"42","author":"Francois","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"e80319","DOI":"10.1371\/journal.pone.0080319","article-title":"Abnormal trafficking of endogenously expressed bmpr2 mutant allelic products in patients with heritable pulmonary arterial hypertension","volume":"8","author":"Frump","year":"2013","journal-title":"PLoS One"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1801965","DOI":"10.1183\/13993003.01965-2018","article-title":"Phenotype characterisation of tbx4 mutation and deletion carriers with neonatal and paediatric pulmonary hypertension","volume":"54","author":"Galambos","year":"2019","journal-title":"Eur. Respir. J."},{"key":"B60","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.nano.2018.12.018","article-title":"Non-viral vectors based on cationic niosomes and minicircle DNA technology enhance gene delivery efficiency for biomedical applications in retinal disorders","volume":"17","author":"Gallego","year":"2019","journal-title":"Nanomedicine"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/hgtb.2017.098","article-title":"Manufacture of third-generation lentivirus for preclinical use, with process development considerations for translation to good manufacturing practice","volume":"29","author":"Gandara","year":"2018","journal-title":"Hum. Gene Ther. Methods"},{"key":"B62","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cytogfr.2015.12.005","article-title":"Bmp signaling in vascular biology and dysfunction","volume":"27","author":"Garcia de Vinuesa","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"key":"B63","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12881-017-0440-5","article-title":"A systematic review of genetic mutations in pulmonary arterial hypertension","volume":"18","author":"Garcia-Rivas","year":"2017","journal-title":"BMC Med. Genet."},{"key":"B64","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1164\/rccm.200908-1284OC","article-title":"Clinical outcomes of pulmonary arterial hypertension in patients carrying an acvrl1 (alk1) mutation","volume":"181","author":"Girerd","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1016\/j.ajpath.2015.03.019","article-title":"Endothelial to mesenchymal transition contributes to endothelial dysfunction in pulmonary arterial hypertension","volume":"185","author":"Good","year":"2015","journal-title":"Am. J. Pathol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"e100310","DOI":"10.1371\/journal.pone.0100310","article-title":"Key role of the endothelial TGF-\u03b2\/ALK1\/endoglin signaling pathway in humans and rodents pulmonary hypertension","volume":"9","author":"Gore","year":"2014","journal-title":"PLoS One"},{"key":"B67","doi-asserted-by":"publisher","first-page":"a031989","DOI":"10.1101\/cshperspect.a031989","article-title":"Bone morphogenetic proteins in vascular homeostasis and disease","volume":"10","author":"Goumans","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1038\/s41467-018-03672-4","article-title":"Identification of rare sequence variation underlying heritable pulmonary arterial hypertension","volume":"9","author":"Graf","year":"2018","journal-title":"Nat. Commun."},{"key":"B69","doi-asserted-by":"publisher","first-page":"L371","DOI":"10.1152\/ajplung.00532.2016","article-title":"Peroxisome proliferator-activated receptor-gamma enhances human pulmonary artery smooth muscle cell apoptosis through microrna-21 and programmed cell death 4","volume":"313","author":"Green","year":"2017","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2217\/fvl.11.6","article-title":"Implications of the innate immune response to adenovirus and adenoviral vectors","volume":"6","author":"Gregory","year":"2011","journal-title":"Future Virol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"9933","DOI":"10.1128\/JVI.79.15.9933-9944.2005","article-title":"Packaging capacity of adeno-associated virus serotypes: Impact of larger genomes on infectivity and postentry steps","volume":"79","author":"Grieger","year":"2005","journal-title":"J. Virol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1164\/rccm.201206-1056OC","article-title":"Assessment of f\/hn-pseudotyped lentivirus as a clinically relevant vector for lung gene therapy","volume":"186","author":"Griesenbach","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1517\/14712598.4.6.901","article-title":"Vaccinia as a vector for gene delivery","volume":"4","author":"Guo","year":"2004","journal-title":"Expert Opin. Biol. Ther."},{"key":"B74","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jpeds.2020.05.051","article-title":"The genetic epidemiology of pediatric pulmonary arterial hypertension","volume":"225","author":"Haarman","year":"2020","journal-title":"J. Pediatr."},{"key":"B75","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/nbt0702-697","article-title":"Efficient mouse airway transduction following recombination between aav vectors carrying parts of a larger gene","volume":"20","author":"Halbert","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1089\/hum.2007.161","article-title":"Stable integration of recombinant adeno-associated virus vector genomes after transduction of murine hematopoietic stem cells","volume":"19","author":"Han","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"B77","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1183\/09031936.00065713","article-title":"Registries for paediatric pulmonary hypertension","volume":"42","author":"Hansmann","year":"2013","journal-title":"Eur. Respir. J."},{"key":"B78","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/resp.12729","article-title":"Bmpr2 gene therapy for pah acts via smad and non-smad signalling","volume":"21","author":"Harper","year":"2016","journal-title":"Respirology"},{"key":"B79","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1161\/01.CIR.0000153798.78540.87","article-title":"Transforming growth factor-beta receptor mutations and pulmonary arterial hypertension in childhood","volume":"111","author":"Harrison","year":"2005","journal-title":"Circulation"},{"key":"B80","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1136\/jmg.40.12.865","article-title":"Molecular and functional analysis identifies alk-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia","volume":"40","author":"Harrison","year":"2003","journal-title":"J. Med. Genet."},{"key":"B81","doi-asserted-by":"publisher","first-page":"7791","DOI":"10.1128\/MCB.00022-06","article-title":"Different routes of bone morphogenic protein (bmp) receptor endocytosis influence bmp signaling","volume":"26","author":"Hartung","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/978-3-642-00477-3_6","article-title":"Pulmonary drug delivery: Medicines for inhalation","volume":"197","author":"Henning","year":"2010","journal-title":"Handb. Exp. Pharmacol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"8549","DOI":"10.1128\/JVI.73.10.8549-8558.1999","article-title":"Latent adeno-associated virus infection elicits humoral but not cell-mediated immune responses in a nonhuman primate model","volume":"73","author":"Hernandez","year":"1999","journal-title":"J. Virol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.tibtech.2015.11.004","article-title":"Overcoming gene-delivery hurdles: Physiological considerations for nonviral vectors","volume":"34","author":"Hill","year":"2016","journal-title":"Trends Biotechnol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0065-3527(06)68008-1","article-title":"Baculovirus vectors for gene therapy","volume":"68","author":"Hu","year":"2006","journal-title":"Adv. Virus Res."},{"key":"B86","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/s0092-8674(00)80423-7","article-title":"Xsox17alpha and -beta mediate endoderm formation in xenopus","volume":"91","author":"Hudson","year":"1997","journal-title":"Cell"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1164\/rccm.200510-1668OC","article-title":"Pulmonary arterial hypertension in France: Results from a national registry","volume":"173","author":"Humbert","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B88","doi-asserted-by":"publisher","first-page":"14079","DOI":"10.1038\/ncomms14079","article-title":"TNF\u03b1 drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling","volume":"8","author":"Hurst","year":"2017","journal-title":"Nat. Commun."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1002\/jgm.597","article-title":"Recombinant sendai virus vectors deleted in both the matrix and the fusion genes: Efficient gene transfer with preferable properties","volume":"6","author":"Inoue","year":"2004","journal-title":"J. Gene Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/79226","article-title":"Heterozygous germline mutations in bmpr2, encoding a tgf-beta receptor, cause familial primary pulmonary hypertension","volume":"26","author":"International","year":"2000","journal-title":"Nat. Genet."},{"key":"B91","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/HCO.0000000000000822","article-title":"Update on pediatric pulmonary arterial hypertension","volume":"36","author":"Ivy","year":"2021","journal-title":"Curr. Opin. Cardiol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"D117","DOI":"10.1016\/j.jacc.2013.10.028","article-title":"Pediatric pulmonary hypertension","volume":"62","author":"Ivy","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/ncb3534","article-title":"Endoglin prevents vascular malformation by regulating flow-induced cell migration and specification through vegfr2 signalling","volume":"19","author":"Jin","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"589","DOI":"10.18388\/abp.2005_3419","article-title":"Helper-dependent adenoviral vectors in experimental gene therapy","volume":"52","author":"Jozkowicz","year":"2005","journal-title":"Acta Biochim. Pol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12931-022-02005-w","article-title":"Crispr-mediated bmpr2 point mutation exacerbates late pulmonary vasculopathy and reduces survival in rats with experimental pulmonary hypertension","volume":"23","author":"Kabwe","year":"2022","journal-title":"Respir. Res."},{"key":"B96","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1242\/dev.129.10.2367","article-title":"Depletion of definitive gut endoderm in sox17-null mutant mice","volume":"129","author":"Kanai-Azuma","year":"2002","journal-title":"Development"},{"key":"B97","doi-asserted-by":"publisher","first-page":"E8","DOI":"10.3390\/jcdd6010008","article-title":"Targeted gene delivery through the respiratory system: Rationale for intratracheal gene transfer","volume":"6","author":"Katz","year":"2019","journal-title":"J. Cardiovasc. Dev. Dis."},{"key":"B98","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1089\/humc.2017.070","article-title":"Use of adeno-associated virus vector for cardiac gene delivery in large-animal surgical models of heart failure","volume":"28","author":"Katz","year":"2017","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"B99","first-page":"748","article-title":"Recombinant adeno-associated virus (aav-cftr) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line","volume":"3","author":"Kearns","year":"1996","journal-title":"Gene Ther."},{"key":"B100","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1136\/jmedgenet-2012-101152","article-title":"Tbx4 mutations (small patella syndrome) are associated with childhood-onset pulmonary arterial hypertension","volume":"50","author":"Kerstjens-Frederikse","year":"2013","journal-title":"J. Med. Genet."},{"key":"B101","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.cell.2007.06.011","article-title":"Sox17 dependence distinguishes the transcriptional regulation of fetal from adult hematopoietic stem cells","volume":"130","author":"Kim","year":"2007","journal-title":"Cell"},{"key":"B102","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1161\/CIRCRESAHA.116.308483","article-title":"Soxf transcription factors are positive feedback regulators of vegf signaling","volume":"119","author":"Kim","year":"2016","journal-title":"Circ. Res."},{"key":"B103","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"key":"B104","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ydbio.2013.11.018","article-title":"Sox17 is required for normal pulmonary vascular morphogenesis","volume":"387","author":"Lange","year":"2014","journal-title":"Dev. Biol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"E1261","DOI":"10.3390\/biom10091261","article-title":"Implication of potassium channels in the pathophysiology of pulmonary arterial hypertension","volume":"10","author":"Le Ribeuz","year":"2020","journal-title":"Biomolecules"},{"key":"B106","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.gendis.2017.04.001","article-title":"Adenovirus-mediated gene delivery: Potential applications for gene and cell-based therapies in the new era of personalized medicine","volume":"4","author":"Lee","year":"2017","journal-title":"Genes Dis."},{"key":"B107","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1161\/CIRCRESAHA.115.303142","article-title":"Notch pathway targets proangiogenic regulator sox17 to restrict angiogenesis","volume":"115","author":"Lee","year":"2014","journal-title":"Circ. Res."},{"key":"B108","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3390\/ijms17050761","article-title":"Molecular mechanisms of pulmonary vascular remodeling in pulmonary arterial hypertension","volume":"17","author":"Leopold","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1183\/13993003.00211-2016","article-title":"Genetic analyses in a cohort of children with pulmonary hypertension","volume":"48","author":"Levy","year":"2016","journal-title":"Eur. Respir. J."},{"key":"B110","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41576-019-0205-4","article-title":"Engineering adeno-associated virus vectors for gene therapy","volume":"21","author":"Li","year":"2020","journal-title":"Nat. Rev. Genet."},{"key":"B111","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1086\/690007","article-title":"Pulmonary arterial hypertension in the USA: An epidemiological study in a large insured pediatric population","volume":"7","author":"Li","year":"2017","journal-title":"Pulm. Circ."},{"key":"B112","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.coph.2015.07.006","article-title":"Adeno-associated virus serotypes for gene therapeutics","volume":"24","author":"Lisowski","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1128\/mcb.15.7.3479","article-title":"Human type ii receptor for bone morphogenic proteins (bmps): Extension of the two-kinase receptor model to the bmps","volume":"15","author":"Liu","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1038\/s41467-019-10134-y","article-title":"Sox17 is required for endothelial regeneration following inflammation-induced vascular injury","volume":"10","author":"Liu","year":"2019","journal-title":"Nat. Commun."},{"key":"B115","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1073\/pnas.0609100104","article-title":"Sox17 is essential for the specification of cardiac mesoderm in embryonic stem cells","volume":"104","author":"Liu","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B116","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/gt.2013.13","article-title":"Efficient transduction of vascular smooth muscle cells with a translational aav2.5 vector: A new perspective for in-stent restenosis gene therapy","volume":"20","author":"Lompre","year":"2013","journal-title":"Gene Ther."},{"key":"B117","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/path.4833","article-title":"The role of genetics in pulmonary arterial hypertension","volume":"241","author":"Ma","year":"2017","journal-title":"J. Pathol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1056\/NEJMoa1211097","article-title":"A novel channelopathy in pulmonary arterial hypertension","volume":"369","author":"Ma","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"B119","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1016\/j.jacc.2009.04.015","article-title":"Genetics and genomics of pulmonary arterial hypertension","volume":"54","author":"Machado","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/humu.22904","article-title":"Pulmonary arterial hypertension: A current perspective on established and emerging molecular genetic defects","volume":"36","author":"Machado","year":"2015","journal-title":"Hum. Mutat."},{"key":"B121","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/nmeth.2598","article-title":"Crispr rna-guided activation of endogenous human genes","volume":"10","author":"Maeder","year":"2013","journal-title":"Nat. Methods"},{"key":"B122","doi-asserted-by":"publisher","first-page":"L865","DOI":"10.1152\/ajplung.00079.2007","article-title":"Increased pulmonary vascular resistance and defective pulmonary artery filling in caveolin-1-\/- mice","volume":"294","author":"Maniatis","year":"2008","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s41598-017-00662-2","article-title":"Delivery of enac sirna to epithelial cells mediated by a targeted nanocomplex: A therapeutic strategy for cystic fibrosis","volume":"7","author":"Manunta","year":"2017","journal-title":"Sci. Rep."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1091\/mbc.E16-11-0790","article-title":"Aberrant caveolin-1-mediated smad signaling and proliferation identified by analysis of adenine 474 deletion mutation (c.474dela) in patient fibroblasts: A new perspective on the mechanism of pulmonary hypertension","volume":"28","author":"Marsboom","year":"2017","journal-title":"Mol. Biol. Cell"},{"key":"B125","doi-asserted-by":"publisher","first-page":"L872","DOI":"10.1152\/ajplung.00309.2006","article-title":"Overexpression of human bone morphogenetic protein receptor 2 does not ameliorate monocrotaline pulmonary arterial hypertension","volume":"292","author":"McMurtry","year":"2007","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s41375-018-0106-0","article-title":"Clinical use of lentiviral vectors","volume":"32","author":"Milone","year":"2018","journal-title":"Leukemia"},{"key":"B127","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1182\/blood-2013-01-306647","article-title":"Immune responses to aav vectors: Overcoming barriers to successful gene therapy","volume":"122","author":"Mingozzi","year":"2013","journal-title":"Blood"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/mt.2010.13","article-title":"Toward gene therapy for cystic fibrosis using a lentivirus pseudotyped with sendai virus envelopes","volume":"18","author":"Mitomo","year":"2010","journal-title":"Mol. Ther."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1002\/iub.2296","article-title":"Crispr\/cas9 gene editing: A new therapeutic approach in the treatment of infection and autoimmunity","volume":"72","author":"Mohammadzadeh","year":"2020","journal-title":"IUBMB Life"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1136\/hrt.2009.182378","article-title":"Childhood idiopathic pulmonary arterial hypertension: A national cohort study","volume":"96","author":"Moledina","year":"2010","journal-title":"Heart"},{"key":"B131","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1183\/13993003.00717-2015","article-title":"Genetic counselling in a national referral centre for pulmonary hypertension","volume":"58","author":"Montani","year":"2021","journal-title":"Eur. Respir. J."},{"key":"B132","doi-asserted-by":"publisher","first-page":"1801899","DOI":"10.1183\/13993003.01899-2018","article-title":"Genetics and genomics of pulmonary arterial hypertension","volume":"53","author":"Morrell","year":"2019","journal-title":"Eur. Respir. J."},{"key":"B133","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1089\/hum.2007.022","article-title":"Repeated aerosolized aav-cftr for treatment of cystic fibrosis: A randomized placebo-controlled phase 2b trial","volume":"18","author":"Moss","year":"2007","journal-title":"Hum. Gene Ther."},{"key":"B134","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1161\/01.ATV.0000174130.75958.b7","article-title":"Vascular endothelium has a local anti-adenovirus vector system and glucocorticoid optimizes its gene transduction","volume":"25","author":"Murata","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1242\/dev.00504","article-title":"Loss of tbx4 blocks hindlimb development and affects vascularization and fusion of the allantois","volume":"130","author":"Naiche","year":"2003","journal-title":"Development"},{"key":"B136","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41417-019-0116-8","article-title":"Translatable gene therapy for lung cancer using crispr cas9-an exploratory review","volume":"27","author":"Nair","year":"2020","journal-title":"Cancer Gene Ther."},{"key":"B137","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1002\/humu.21605","article-title":"Molecular genetic characterization of smad signaling molecules in pulmonary arterial hypertension","volume":"32","author":"Nasim","year":"2011","journal-title":"Hum. Mutat."},{"key":"B138","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s40259-017-0234-5","article-title":"Adeno-associated virus (aav) as a vector for gene therapy","volume":"31","author":"Naso","year":"2017","journal-title":"BioDrugs"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.rec.2016.03.029","article-title":"Molecular analysis of bmpr2, tbx4, and kcnk3 and genotype-phenotype correlations in Spanish patients and families with idiopathic and hereditary pulmonary arterial hypertension","volume":"69","author":"Navas","year":"2016","journal-title":"Rev. Esp. Cardiol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1182\/blood-2009-07-235655","article-title":"Alk1 signaling regulates early postnatal lymphatic vessel development","volume":"115","author":"Niessen","year":"2010","journal-title":"Blood"},{"key":"B141","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/ajmg.a.33827","article-title":"Microdeletion of 17q22q23.2 encompassing tbx2 and tbx4 in a patient with congenital microcephaly, thyroid duct cyst, sensorineural hearing loss, and pulmonary hypertension","author":"Nimmakayalu","year":"2011","journal-title":"Am. J. Med. Genet. A"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1161\/01.RES.0000219677.12988.e9","article-title":"Impact of task-1 in human pulmonary artery smooth muscle cells","volume":"98","author":"Olschewski","year":"2006","journal-title":"Circ. Res."},{"key":"B143","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/978-1-60761-500-2_30","article-title":"Targeting task-1 channels as a therapeutic approach","volume":"661","author":"Olschewski","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"1700754","DOI":"10.1183\/13993003.00754-2017","article-title":"Task-1 (kcnk3) channels in the lung: From cell biology to clinical implications","volume":"50","author":"Olschewski","year":"2017","journal-title":"Eur. Respir. J."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/hum.2005.16.1","article-title":"Helper-dependent adenoviral vectors for gene therapy","volume":"16","author":"Palmer","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"B146","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/gt.2013.44","article-title":"Pseudotyping the adenovirus serotype 5 capsid with both the fibre and penton of serotype 35 enhances vascular smooth muscle cell transduction","volume":"20","author":"Parker","year":"2013","journal-title":"Gene Ther."},{"key":"B147","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1183\/09031936.00092306","article-title":"An epidemiological study of pulmonary arterial hypertension","volume":"30","author":"Peacock","year":"2007","journal-title":"Eur. Respir. J."},{"key":"B148","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1042\/CS20160247","article-title":"Identification of multiple acvrl1 mutations in patients with pulmonary arterial hypertension by targeted exome capture","volume":"130","author":"Piao","year":"2016","journal-title":"Clin. Sci."},{"key":"B149","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.cell.2013.02.022","article-title":"Repurposing crispr as an rna-guided platform for sequence-specific control of gene expression","volume":"152","author":"Qi","year":"2013","journal-title":"Cell"},{"key":"B150","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1139\/o03-071","article-title":"Caveolins, caveolae, and lipid rafts in cellular transport, signaling, and disease","volume":"82","author":"Quest","year":"2004","journal-title":"Biochem. Cell Biol."},{"key":"B151","first-page":"22","article-title":"Genetic delivery and gene therapy in pulmonary hypertension","author":"Rai","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B152","doi-asserted-by":"publisher","first-page":"GE01","DOI":"10.7860\/JCDR\/2015\/10443.5394","article-title":"Non viral vectors in gene therapy- an overview","volume":"9","author":"Ramamoorth","year":"2015","journal-title":"J. Clin. Diagn. Res."},{"key":"B153","doi-asserted-by":"publisher","first-page":"319","DOI":"10.4155\/tde-2016-0006","article-title":"Mrna vaccine delivery using lipid nanoparticles","volume":"7","author":"Reichmuth","year":"2016","journal-title":"Ther. Deliv."},{"key":"B154","doi-asserted-by":"publisher","first-page":"L1182","DOI":"10.1152\/ajplung.00020.2006","article-title":"Bone morphogenetic protein type 2 receptor gene therapy attenuates hypoxic pulmonary hypertension","volume":"292","author":"Reynolds","year":"2007","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"B155","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1517\/14712598.2011.542139","article-title":"Gene therapy for pulmonary hypertension: Prospects and challenges","volume":"11","author":"Reynolds","year":"2011","journal-title":"Expert Opin. Biol. Ther."},{"key":"B156","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2016.06.023","article-title":"Progress in the development of lipopolyplexes as efficient non-viral gene delivery systems","volume":"236","author":"Rezaee","year":"2016","journal-title":"J. Control. Release"},{"key":"B157","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1164\/ajrccm\/140.4.1126","article-title":"Regulation of endothelial cell growth, architecture, and matrix synthesis by tgf-beta","volume":"140","author":"Roberts","year":"1989","journal-title":"Am. Rev. Respir. Dis."},{"key":"B158","doi-asserted-by":"publisher","first-page":"1801916","DOI":"10.1183\/13993003.01916-2018","article-title":"Paediatric pulmonary arterial hypertension: Updates on definition, classification, diagnostics and management","volume":"53","author":"Rosenzweig","year":"2019","journal-title":"Eur. Respir. J."},{"key":"B159","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.healun.2008.02.009","article-title":"Clinical implications of determining bmpr2 mutation status in a large cohort of children and adults with pulmonary arterial hypertension","volume":"27","author":"Rosenzweig","year":"2008","journal-title":"J. Heart Lung Transpl."},{"key":"B160","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/S0140-6736(03)13167-4","article-title":"Primary pulmonary hypertension","volume":"361","author":"Runo","year":"2003","journal-title":"Lancet"},{"key":"B161","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1001\/jama.2022.4402","article-title":"Diagnosis and treatment of pulmonary arterial hypertension: A review","volume":"327","author":"Ruopp","year":"2022","journal-title":"JAMA"},{"key":"B162","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/j.celrep.2017.05.011","article-title":"Structural basis of the human endoglin-bmp9 interaction: Insights into bmp signaling and hht1","volume":"19","author":"Saito","year":"2017","journal-title":"Cell Rep."},{"key":"B163","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1242\/dev.00345","article-title":"Tbx4-fgf10 system controls lung bud formation during chicken embryonic development","volume":"130","author":"Sakiyama","year":"2003","journal-title":"Development"},{"key":"B164","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1109\/IEMBS.2004.1403990","article-title":"Directed evolution of aav mutants for enhanced gene delivery","volume":"2004","author":"Schaffer","year":"2004","journal-title":"Conf. Proc. IEEE Eng. Med. Biol. Soc."},{"key":"B165","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1242\/jcs.002949","article-title":"Bmp-9 signals via alk1 and inhibits bfgf-induced endothelial cell proliferation and vegf-stimulated angiogenesis","volume":"120","author":"Scharpfenecker","year":"2007","journal-title":"J. Cell Sci."},{"key":"B166","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/mt.2008.103","article-title":"Recombinant adeno-associated virus transduction and integration","volume":"16","author":"Schultz","year":"2008","journal-title":"Mol. Ther."},{"key":"B167","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1161\/01.RES.0000095246.40391.3B","article-title":"Arterial endothelium-specific activin receptor-like kinase 1 expression suggests its role in arterialization and vascular remodeling","volume":"93","author":"Seki","year":"2003","journal-title":"Circ. Res."},{"key":"B168","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/5096","article-title":"Fgf10 is essential for limb and lung formation","volume":"21","author":"Sekine","year":"1999","journal-title":"Nat. Genet."},{"key":"B169","doi-asserted-by":"publisher","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur. Respir. J."},{"key":"B170","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1038\/mtna.2012.47","article-title":"Lentiviral vector gene transfer to porcine airways","volume":"1","author":"Sinn","year":"2012","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B171","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/hum.2016.152","article-title":"Genetic modification of the lung directed toward treatment of human disease","volume":"28","author":"Sondhi","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"B172","doi-asserted-by":"publisher","first-page":"e41460","DOI":"10.1371\/journal.pone.0041460","article-title":"Activation of the canonical bone morphogenetic protein (bmp) pathway during lung morphogenesis and adult lung tissue repair","volume":"7","author":"Sountoulidis","year":"2012","journal-title":"PLoS One"},{"key":"B173","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41569-019-0242-x","article-title":"Molecular genetic framework underlying pulmonary arterial hypertension","volume":"17","author":"Southgate","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/sj.gt.3302071","article-title":"Gene therapy progress and prospects: Adenoviral vectors","volume":"10","author":"St George","year":"2003","journal-title":"Gene Ther."},{"key":"B175","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/ncb3528","article-title":"Endoglin controls blood vessel diameter through endothelial cell shape changes in response to haemodynamic cues","volume":"19","author":"Sugden","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"B176","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/00001503-200402000-00004","article-title":"Gene therapy in heart and lung disease","volume":"17","author":"Szokol","year":"2004","journal-title":"Curr. Opin. Anaesthesiol."},{"key":"B177","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nrg1066","article-title":"Progress and problems with the use of viral vectors for gene therapy","volume":"4","author":"Thomas","year":"2003","journal-title":"Nat. Rev. Genet."},{"key":"B178","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3389\/fgene.2014.00456","article-title":"Emerging roles of bmp9 and bmp10 in hereditary hemorrhagic telangiectasia","volume":"5","author":"Tillet","year":"2014","journal-title":"Front. Genet."},{"key":"B179","doi-asserted-by":"publisher","first-page":"10963","DOI":"10.1074\/jbc.RA118.002968","article-title":"A heterodimer formed by bone morphogenetic protein 9 (bmp9) and bmp10 provides most bmp biological activity in plasma","volume":"293","author":"Tillet","year":"2018","journal-title":"J. Biol. Chem."},{"key":"B180","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1056\/NEJM200108023450503","article-title":"Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia","volume":"345","author":"Trembath","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"B181","doi-asserted-by":"publisher","first-page":"D4","DOI":"10.1016\/j.jacc.2013.10.025","article-title":"Relevant issues in the pathology and pathobiology of pulmonary hypertension","volume":"62","author":"Tuder","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"B182","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/978-1-4939-6588-5_10","article-title":"Lipidoid mrna nanoparticles for myocardial delivery in rodents","volume":"1521","author":"Turnbull","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"B183","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/mt.2015.193","article-title":"Myocardial delivery of lipidoid nanoparticle carrying modrna induces rapid and transient expression","volume":"24","author":"Turnbull","year":"2016","journal-title":"Mol. Ther."},{"key":"B184","doi-asserted-by":"publisher","first-page":"E1191","DOI":"10.3390\/genes11101191","article-title":"Genetic evaluation in a cohort of 126 Dutch pulmonary arterial hypertension patients","volume":"11","author":"van den Heuvel","year":"2020","journal-title":"Genes"},{"key":"B185","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1080\/14712598.2018.1506761","article-title":"Lessons learned from lung and liver in-vivo gene therapy: Implications for the future","volume":"18","author":"van Haasteren","year":"2018","journal-title":"Expert Opin. Biol. Ther."},{"key":"B186","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1161\/CIRCULATIONAHA.110.969584","article-title":"Pediatric pulmonary hypertension in The Netherlands: Epidemiology and characterization during the period 1991 to 2005","volume":"124","author":"van Loon","year":"2011","journal-title":"Circulation"},{"key":"B187","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/cge.13103","article-title":"Small patella syndrome: New clinical and molecular insights into a consistent phenotype","volume":"92","author":"Vanlerberghe","year":"2017","journal-title":"Clin. Genet."},{"key":"B188","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/nm1429","article-title":"Soluble endoglin contributes to the pathogenesis of preeclampsia","volume":"12","author":"Venkatesha","year":"2006","journal-title":"Nat. Med."},{"key":"B189","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1089\/104454904323090903","article-title":"Simian virus-40 as a gene therapy vector","volume":"23","author":"Vera","year":"2004","journal-title":"DNA Cell Biol."},{"key":"B190","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.ymthe.2019.12.010","article-title":"Aav vector immunogenicity in humans: A long journey to successful gene transfer","volume":"28","author":"Verdera","year":"2020","journal-title":"Mol. Ther."},{"key":"B191","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.3390\/v2091886","article-title":"Gene therapy with helper-dependent adenoviral vectors: Current advances and future perspectives","volume":"2","author":"Vetrini","year":"2010","journal-title":"Viruses"},{"key":"B192","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrg2141","article-title":"Engineering targeted viral vectors for gene therapy","volume":"8","author":"Waehler","year":"2007","journal-title":"Nat. Rev. Genet."},{"key":"B193","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"B194","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1536\/ihj.20-711","article-title":"Sox17 loss-of-function mutation underlying familial pulmonary arterial hypertension","volume":"62","author":"Wang","year":"2021","journal-title":"Int. Heart J."},{"key":"B195","doi-asserted-by":"publisher","first-page":"1801609","DOI":"10.1183\/13993003.01609-2018","article-title":"Germline bmp9 mutation causes idiopathic pulmonary arterial hypertension","volume":"53","author":"Wang","year":"2019","journal-title":"Eur. Respir. J."},{"key":"B196","doi-asserted-by":"publisher","first-page":"109765","DOI":"10.1016\/j.biopha.2019.109765","article-title":"Development of a novel bivalent baculovirus vectors for complement resistance and sustained transgene expression and its application in anti-angiogenesis gene therapy","volume":"123","author":"Wang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"B197","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/gt.2010.87","article-title":"Aavrh.10-mediated genetic delivery of bevacizumab to the pleura to provide local anti-vegf to suppress growth of metastatic lung tumors","volume":"17","author":"Watanabe","year":"2010","journal-title":"Gene Ther."},{"key":"B198","doi-asserted-by":"publisher","first-page":"2045894018799738","DOI":"10.1177\/2045894018799738","article-title":"Safety and long-term efficacy of aav1.Serca2a using nebulizer delivery in a pig model of pulmonary hypertension","volume":"8","author":"Watanabe","year":"2018","journal-title":"Pulm. Circ."},{"key":"B199","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1006\/mthe.2002.0662","article-title":"Delivery of gene transfer vectors to lung: Obstacles and the role of adjunct techniques for airway administration","volume":"6","author":"Weiss","year":"2002","journal-title":"Mol. Ther."},{"key":"B200","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/ppul.24637","article-title":"Genes that drive the pathobiology of pediatric pulmonary arterial hypertension","volume":"56","author":"Welch","year":"2021","journal-title":"Pediatr. Pulmonol."},{"key":"B201","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.chest.2020.01.013","article-title":"Genetics and other omics in pediatric pulmonary arterial hypertension","volume":"157","author":"Welch","year":"2020","journal-title":"Chest"},{"key":"B202","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.bbrc.2008.08.066","article-title":"Caveolin-1 regulates bmprii localization and signaling in vascular smooth muscle cells","volume":"375","author":"Wertz","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B203","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ymthe.2006.05.009","article-title":"Adeno-associated virus serotypes: Vector toolkit for human gene therapy","volume":"14","author":"Wu","year":"2006","journal-title":"Mol. Ther."},{"key":"B204","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1089\/hum.2017.060","article-title":"Human bocavirus type-1 capsid facilitates the transduction of ferret airways by adeno-associated virus genomes","volume":"28","author":"Yan","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"B205","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1038\/mt.2013.92","article-title":"A novel chimeric adenoassociated virus 2\/human bocavirus 1 parvovirus vector efficiently transduces human airway epithelia","volume":"21","author":"Yan","year":"2013","journal-title":"Mol. Ther."},{"key":"B206","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1161\/01.RES.0000166926.54293.68","article-title":"Dysfunctional smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension","volume":"96","author":"Yang","year":"2005","journal-title":"Circ. Res."},{"key":"B207","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non-viral vectors for gene-based therapy","volume":"15","author":"Yin","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"B208","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1002\/dvdy.20565","article-title":"Sox7 and sox18 are essential for cardiogenesis in xenopus","volume":"234","author":"Zhang","year":"2005","journal-title":"Dev. Dyn."},{"key":"B209","doi-asserted-by":"publisher","first-page":"R40","DOI":"10.1093\/hmg\/ddu125","article-title":"Crispr\/cas9 for genome editing: Progress, implications and challenges","volume":"23","author":"Zhang","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"B210","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1016\/j.cjca.2019.07.628","article-title":"Genotypes and phenotypes of Chinese pediatric patients with idiopathic and heritable pulmonary arterial hypertension-a single-center study","volume":"35","author":"Zhang","year":"2019","journal-title":"Can. J. Cardiol."},{"key":"B211","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1161\/CIRCULATIONAHA.116.025722","article-title":"Sox17 regulates conversion of human fibroblasts into endothelial cells and erythroblasts by dedifferentiation into cd34(+) progenitor cells","volume":"135","author":"Zhang","year":"2017","journal-title":"Circulation"},{"key":"B212","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1165\/rcmb.2005-0115OC","article-title":"Microvascular regeneration in established pulmonary hypertension by angiogenic gene transfer","volume":"35","author":"Zhao","year":"2006","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B213","doi-asserted-by":"publisher","first-page":"7827","DOI":"10.1073\/pnas.0802866105","article-title":"Next generation of adeno-associated virus 2 vectors: Point mutations in tyrosines lead to high-efficiency transduction at lower doses","volume":"105","author":"Zhong","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B214","doi-asserted-by":"publisher","first-page":"e001887","DOI":"10.1161\/CIRCGEN.117.001887","article-title":"Exome sequencing in children with pulmonary arterial hypertension demonstrates differences compared with adults","volume":"11","author":"Zhu","year":"2018","journal-title":"Circ. Genom. Precis. Med."},{"key":"B215","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13073-019-0685-z","article-title":"Novel risk genes and mechanisms implicated by exome sequencing of 2572 individuals with pulmonary arterial hypertension","volume":"11","author":"Zhu","year":"2019","journal-title":"Genome Med."},{"key":"B216","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13073-018-0566-x","article-title":"Rare variants in sox17 are associated with pulmonary arterial hypertension with congenital heart disease","volume":"10","author":"Zhu","year":"2018","journal-title":"Genome Med."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.961848\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T11:29:32Z","timestamp":1669289372000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.961848\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,24]]},"references-count":216,"alternative-id":["10.3389\/fgene.2022.961848"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2022.961848","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,24]]},"article-number":"961848"}}